Lu Xiao

579 total citations
33 papers, 324 citations indexed

About

Lu Xiao is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Lu Xiao has authored 33 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Rheumatology. Recurrent topics in Lu Xiao's work include Cancer-related molecular mechanisms research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Lu Xiao is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Lu Xiao collaborates with scholars based in China, United Kingdom and United States. Lu Xiao's co-authors include Feng Zhan, Jing Zhu, Zhen-Zhen Xue, Jing Meng, Chao Yang, Erwei Sun, Jun Feng, Lei Zhang, Fang Li and Liang Zhao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Lu Xiao

29 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Xiao China 11 130 75 55 41 40 33 324
Li Hou China 12 129 1.0× 89 1.2× 51 0.9× 23 0.6× 26 0.7× 38 377
Ana R. Coelho Portugal 8 211 1.6× 44 0.6× 65 1.2× 34 0.8× 14 0.3× 16 322
Miaoqin She China 7 164 1.3× 43 0.6× 20 0.4× 28 0.7× 56 1.4× 11 417
Donald Souza United States 8 81 0.6× 68 0.9× 33 0.6× 23 0.6× 40 1.0× 11 263
Hina Khan United States 11 145 1.1× 46 0.6× 66 1.2× 13 0.3× 34 0.8× 45 368
Xia Zhan China 13 181 1.4× 52 0.7× 21 0.4× 127 3.1× 29 0.7× 39 376
Yue-Fen Wang China 11 136 1.0× 49 0.7× 43 0.8× 43 1.0× 16 0.4× 26 427
Junlong Ma China 10 90 0.7× 37 0.5× 21 0.4× 48 1.2× 35 0.9× 50 320
Ahmed Gaafar Ahmed Gaafar Egypt 9 129 1.0× 44 0.6× 22 0.4× 16 0.4× 17 0.4× 16 263

Countries citing papers authored by Lu Xiao

Since Specialization
Citations

This map shows the geographic impact of Lu Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Xiao more than expected).

Fields of papers citing papers by Lu Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Xiao. The network helps show where Lu Xiao may publish in the future.

Co-authorship network of co-authors of Lu Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Xiao. A scholar is included among the top collaborators of Lu Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Xiao. Lu Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Hao, Zhong‐Hua Chen, Zichuan Lv, et al.. (2025). Exploring new strategies for improved aluminium-ion batteries through dual-anion modeling. Applied Energy. 401. 126768–126768.
2.
Yang, Juan, Lu Xiao, Li Lan, et al.. (2025). VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis. Nature Communications. 16(1). 1160–1160. 5 indexed citations
3.
Zhou, Dong, Jiao Zhang, Xu‐Feng Deng, et al.. (2025). SUSD2 hypersialylation promotes early lung adenocarcinoma progression by driving ECM remodeling and pro-tumorigenic fibroblast activation. Cancer Letters. 633. 217995–217995.
4.
5.
Xiao, Lu, et al.. (2023). Downregulation of Sox8 mediates monosodium urate crystal-induced autophagic impairment of cartilage in gout arthritis. Cell Death Discovery. 9(1). 95–95. 11 indexed citations
6.
Xiao, Lu, et al.. (2022). Pulmonary Thrombosis Promotes Tumorigenesis via Myeloid Hypoxia-Inducible Factors. Biomolecules. 12(10). 1354–1354. 5 indexed citations
7.
Xiao, Lu, et al.. (2022). IRF9 and XAF1 as Diagnostic Markers of Primary Sjogren Syndrome. Computational and Mathematical Methods in Medicine. 2022. 1–12. 1 indexed citations
8.
Xiao, Lu, et al.. (2022). Identification of hub genes and transcription factors in patients with rheumatoid arthritis complicated with atherosclerosis. Scientific Reports. 12(1). 4677–4677. 7 indexed citations
9.
Li, Shiming, et al.. (2022). Investigation of Mental Health Literacy and Status of Residents During the Re-Outbreak of COVID-19 in China. Frontiers in Public Health. 10. 895553–895553. 11 indexed citations
10.
Xiao, Lu, et al.. (2022). Potential biomarkers for active renal involvement in systemic lupus erythematosus patients. Frontiers in Medicine. 9. 995103–995103. 5 indexed citations
11.
Xiao, Lu, et al.. (2022). Clinical Values of the Identified Hub Genes in Systemic Lupus Erythematosus. Frontiers in Immunology. 13. 844025–844025. 9 indexed citations
12.
Xiao, Lu, et al.. (2022). One of the active ingredients in Paeoniae Radix Alba functions as JAK1 inhibitor in rheumatoid arthritis. Frontiers in Pharmacology. 13. 906763–906763. 6 indexed citations
13.
Xiao, Lu, et al.. (2021). Ten genes are considered as potential biomarkers for the diagnosis of dermatomyositis. PLoS ONE. 16(11). e0260511–e0260511. 4 indexed citations
14.
Xiao, Lu, et al.. (2019). The association between serum uric acid level and changes of MRI findings in knee osteoarthritis. Medicine. 98(21). e15819–e15819. 14 indexed citations
15.
16.
17.
Xiao, Lu, et al.. (2013). Low molecular weight heparin prevents CLP-Induced acute lung injury in rats by anti-inflammatory coagulation. SHILAP Revista de lepidopterología. 13(1). 50–56. 8 indexed citations
18.
Chen, Zhipeng, Lu Xiao, Wen Liu, et al.. (2012). Novel materials which possess the ability to target liver cells. Expert Opinion on Drug Delivery. 9(6). 649–656. 15 indexed citations
19.
Chen, Zhipeng, Lu Xiao, Dan Liu, et al.. (2011). Synthesis of a novel polymer cholesterol‐poly(ethylene glycol) 2000‐glycyrrhetinic acid (chol‐PEG‐GA) and its application in brucine liposome. Journal of Applied Polymer Science. 124(6). 4554–4563. 10 indexed citations
20.
Xiao, Lu. (2004). Pharmacological Study on Immunosuppressive Fractions F-1C from Fructus corni. Chinese Journal of Natural Medicines. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Hou Breakdown of academic impact, for papers by Ana R. Coelho Breakdown of academic impact, for papers by Miaoqin She Breakdown of academic impact, for papers by Donald Souza Breakdown of academic impact, for papers by Hina Khan Breakdown of academic impact, for papers by Xia Zhan Breakdown of academic impact, for papers by Yue-Fen Wang Breakdown of academic impact, for papers by Junlong Ma Breakdown of academic impact, for papers by Ahmed Gaafar Ahmed Gaafar
Rankless by CCL
2026